Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
DALLAS A big name in smoothies and wellness is approaching its new menu items with those taking weight-loss drugs in mind
Understanding this GLP-1 microbiome connection is the difference between viewing your symptoms as temporary discomfort that resolves on its own and recognizing persistent digestive dysfunction that requires targeted support
Evidence from randomized controlled trials suggests that OA-related knee pain and function improve with semaglutide but not with liraglutide treatment, and observational studies suggest that GLP-1RA use reduces the risk of surgery for knee OA
Clinical trials have shown that GLP-1RAs reduce the incidence of major adverse cardiovascular events in patients with T2DM [6]
The American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society recommend that the dose of semaglutide should be increased slowly and individually, aiming for the highest dose that is both effective and well-tolerated (up to 2.4 mg weekly for obesity)
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
-1781043799568.png&w=3840&q=75)